Prognostication in primary myelofibrosis.

Item

http://www.wikidata.org/entity/Q44731549

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Prognostication in primary myelofibrosis.

@en

Prognostication in primary myelofibrosis.

@nl

type

Item

label

Prognostication in primary myelofibrosis.

@en

Prognostication in primary myelofibrosis.

@nl

prefLabel

Prognostication in primary myelofibrosis.

@en

Prognostication in primary myelofibrosis.

@nl

P1476

Prognostication in primary myelofibrosis.

@en

P2093

Arturo Pereira

http://www.w3.org/2001/XMLSchema#string

Francisco Cervantes

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele.

Identification during the follow-up of time-dependent prognostic factors for the competing risks of death and blast phase in primary myelofibrosis: a study of 172 patients.

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients.

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.

Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.

Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients.

Mature survival data for 176 patients younger than 60 years with primary myelofibrosis diagnosed between 1976 and 2005: evidence for survival gains in recent years.

Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSS.

P2888

s11899-011-0102-1

P304

43-49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11899-011-0102-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22072485

http://www.w3.org/2001/XMLSchema#string